Former Thomson Reuters risk business on the lookout for acquisitions, says CEO

Thomson Reuters completes the sale of its trade and risk management business to Vista Equity Partners, and the new company – called Turaz – already has its eye on acquisitions, says chief executive Bret Bolin

technology arrows

The former Thomson Reuters trade and risk management business - now named Turaz following the sale of the unit to private equity firm Vista - is on the lookout for acquisitions as part of a plan to grow the business.

The sale of the unit to Vista Equity Partners for an undisclosed sum was announced last September, and formally completes today. Already, the new company is looking at how it can expand its reach through acquisition, says Bret Bolin, chief executive and president.

"We are starting

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Register

Want to know what’s included in our free membership? Click here

This address will be used to create your account

AI wide open

The Risk Technology Awards 2018 have highlighted how new technologies are bringing recognition for vendors

Sponsored video: Philip Moyer, Amazon Web Services

Philip Moyer, Enterprise Cloud and Financial Technologies, Amazon Web Services, discusses the biggest government, regulatory and compliance (GRC) challenges organisations face today, how moving to the cloud can help firms prevent potential cyber attacks…

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here